- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03871504
The Influence of Baseline Sensitivity and Expectation on Exercise-induced Hypoalgesia in Young Healthy Adults
March 11, 2019 updated by: Marquette University
Quantitative Sensory Testing, Physical Activity, and Body Composition in Adults
The purpose of this study is to investigate the influence of baseline experimental pain sensitivity and expectation on the pain response following a single exercise session.
Pain assessment will be done with different intensities of noxious stimuli.
In addition, the expectation of how exercise impacts pain will be studied.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The relation between baseline pain sensitivity and the pain response following exercise is not clear.
The aims of this study are to investigate the influence of baseline experimental pain sensitivity on the pain response following submaximal isometric exercise, and whether expectations would influence outcomes with subsequent exposure to exercise.
Study Type
Interventional
Enrollment (Anticipated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Marie Hoeger Bement, PT, PhD
- Phone Number: 414-288-6738
- Email: mariehoeger.bement@marquette.edu
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53201
- Recruiting
- Marquette University
-
Contact:
- Marie Hoeger Bement, PT, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy adults
- English proficiency
Exclusion Criteria:
- Acute pain condition
- Chronic pain condition
- Mental health disorder
- Cardiovascular disease
- Any chronic illness
- Difficulty with physical exercise
- Recent surgery
- Pulmonary disease
- Diabetes
- Smoking
- Raynaud disease
- Claustrophobia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: submaximal isometric exercise.
submaximal isometric exercise will be performed.
|
The exercise is a submaximal isometric contraction
|
|
No Intervention: Quiet rest.
Subject will rest in seating position for a period that mimics the exercise time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change from baseline of pain ratings during temporal summation of pressure pain assessment
Time Frame: Before and immediately after exercise or quiet rest in session 1 and session 2 which will be on day 1 and day 7 of data collection.
|
Temporal summation is the increase of pain over time caused by a constant or repetitive noxious stimulus.
Pain reports will be obtained during the application of constant mechanical stimulus with various intensities.
Subjects will be asked to rate the pain using a numerical pain rating scale that ranges from 0 (no pain) to 10 (worst pain).
Pain ratings will be obtained at the beginning, during, and at the end of the test while a noxious stimulus is applied to the index finger.
The change of pain ratings relative to baseline after exercise or quiet rest will be assessed.
|
Before and immediately after exercise or quiet rest in session 1 and session 2 which will be on day 1 and day 7 of data collection.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Expectation
Time Frame: Before exercise which will be on day 1 and day 7 of data collection.
|
Subjects will be asked about their expectation of whether exercise will increase, decrease, or have no effect on the pain.
|
Before exercise which will be on day 1 and day 7 of data collection.
|
|
State version of the State-Trait Anxiety Inventory (STAI)
Time Frame: After each temporal summation protocol in the first and second session which are on day 1 and day 7 of data collection.
|
A 20-item questionnaire from state-trait anxiety inventory that evaluates different feelings the subject may or may not have at the moment.
The score of the questionnaire ranges from 0 to 80. Higher scores indicate greater state anxiety levels.
|
After each temporal summation protocol in the first and second session which are on day 1 and day 7 of data collection.
|
|
Trait version of the State-Trait Anxiety Inventory (STAI)
Time Frame: Baseline (beginning of session 1) which is day 1 of the data collection.
|
A 20-item questionnaire from state-trait anxiety inventory that evaluates how the subject feels in general and not restricted to the current moment.
The score of the questionnaire ranges from 0 to 80. Higher scores indicate greater trait anxiety levels.
|
Baseline (beginning of session 1) which is day 1 of the data collection.
|
|
Pain catastrophizing scale
Time Frame: Baseline (beginning of session 1) which is day 1 of the data collection.
|
A 13-item scale that evaluates if the subject has an exaggerated negative mental set towards pain.
It has 3 sub-scales which are magnification, rumination, and helplessness.
The scores of the sub-scales are summed to get the total score.
The total score ranges from 0 to 52.
Greater scores indicate greater catastrophizing thinking.
|
Baseline (beginning of session 1) which is day 1 of the data collection.
|
|
Situational pain catastrophizing scale
Time Frame: After each temporal summation protocol in the first and second session which are day 1 and day 7 of data collection.
|
A 6-item questionnaire that explores the negative mental set or catastrophizing thinking in reference to a particular experimental pain experience (i.e., temporal summation protocol).
The score ranges from 0 to 24 with higher scores indicating greater situational catastrophizing.
|
After each temporal summation protocol in the first and second session which are day 1 and day 7 of data collection.
|
|
Physical activity assessment using International physical activity questionnaire.
Time Frame: Baseline (beginning of session 1 or 2) which is either day 1 or day 7 of data collection.
|
International physical activity questionnaire (IPAQ) will be used to assess physical activity in the past week.
IPAQ evaluates physical activity not only related to leisure time but also related to other domains such as transportation, work, gardening or house related physical activities.
The questionnaire has been shown to be reliable and valid.
The time spent in moderate to vigorous physical activity (minutes/ week) from every domain will be summed with 0 indicating no time (minutes / week) spent moderate to vigorous activities and higher values indicate greater time spent in moderate to vigorous physical activity.
|
Baseline (beginning of session 1 or 2) which is either day 1 or day 7 of data collection.
|
|
Muscle mass assessment using Dual-energy x-ray absorptiometry.
Time Frame: Baseline (in the first or second session) which is either day 1 or day 7 of data collection.
|
Dual-energy x-ray absorptiometry (General Electric Healthcare, Madison, Wisconsin) is an x-ray scan that is used to assess muscle mass.
|
Baseline (in the first or second session) which is either day 1 or day 7 of data collection.
|
|
Fat mass assessment using Dual-energy x-ray absorptiometry.
Time Frame: Baseline (in the first or second session) which is either day 1 or day 7 of data collection.
|
Dual-energy x-ray absorptiometry (General Electric Healthcare, Madison, Wisconsin) is an x-ray scan that is used to assess fat mass.
|
Baseline (in the first or second session) which is either day 1 or day 7 of data collection.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marie Hoeger Bement, PT, PhD, Marquette University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 25, 2017
Primary Completion (Anticipated)
December 30, 2022
Study Completion (Anticipated)
December 30, 2022
Study Registration Dates
First Submitted
December 13, 2018
First Submitted That Met QC Criteria
March 11, 2019
First Posted (Actual)
March 12, 2019
Study Record Updates
Last Update Posted (Actual)
March 12, 2019
Last Update Submitted That Met QC Criteria
March 11, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HR-2999
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Healthy Subjects | ImmunosuppressionUnited States
-
Lund UniversityCompletedHealthy Subjects | Diet, HealthySweden
-
Vichy LaboratoiresCentre de Pharmacologie Clinique Applique a la DermatologieCompletedHealthy Subjects | Healthy AdultFrance
-
Yuhan CorporationCompletedAtopic Healthy Subjects | Adult Subjects With Allergic DiseasesKorea, Republic of
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Not yet recruitingHealthy Subjects
-
ZabBio Inc.Boston University; Eunice Kennedy Shriver National Institute of Child Health... and other collaboratorsRecruiting
-
NovoBliss Research Pvt LtdOneSto Labs Private Ltd.Not yet recruiting
Clinical Trials on Submaximal isometric exercise
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Université de ToulonCompletedChronic Obstructive Pulmonary Disease (COPD)France
-
University of Nevada, Las VegasCompletedDown SyndromeUnited States
-
Towson UniversityCompletedEndothelial Dysfunction | Arterial StiffnessUnited States
-
VA Office of Research and DevelopmentCompleted
-
Foundation University IslamabadRecruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
Technical University of MadridRecruiting
-
University of ValenciaCompletedRotator Cuff TendinitisSpain